| Artem Y Vaynman, MD | |
|
9500 Euclid Ave, A41, Cleveland, OH 44195-0001 | |
| (216) 444-2744 | |
| Not Available |
| Full Name | Artem Y Vaynman |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 24 Years |
| Location | 9500 Euclid Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477659787 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 35088611 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nyu Langone Health Home Care | Mineola, NY | Home health agency |
| St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
| New York University Langone Medical Center | New york, NY | Hospital |
| Mercy Medical Center | Rockville centre, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurological Surgery Practice Of Long Island Pllc | 0345131785 | 21 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
ExonHit Therapeutics S.A., a drug and diagnostic discovery company, has announced that Merck & Co., Inc. has been granted a non-exclusive license to rights for research only under Patent US 6,881,571.
The U.S. Department of Veterans Affairs announced on Monday a new effort to improve public health by pushing its research and inventions into commercial markets.
Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.
Today, the Chan Zuckerberg Initiative announced $14 million in funding to support 29 interdisciplinary teams and build a network of researchers that will explore emerging ideas regarding the role of inflammation in disease.
› Verified 9 days ago
| Entity Name | Neurological Surgery Practice Of Long Island Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265529424 PECOS PAC ID: 0345131785 Enrollment ID: O20040323002018 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
ExonHit Therapeutics S.A., a drug and diagnostic discovery company, has announced that Merck & Co., Inc. has been granted a non-exclusive license to rights for research only under Patent US 6,881,571.
The U.S. Department of Veterans Affairs announced on Monday a new effort to improve public health by pushing its research and inventions into commercial markets.
Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.
Today, the Chan Zuckerberg Initiative announced $14 million in funding to support 29 interdisciplinary teams and build a network of researchers that will explore emerging ideas regarding the role of inflammation in disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Artem Y Vaynman, MD 1215 Bonnie Ln, Mayfield Hts, OH 44124-1803 Ph: (440) 473-9533 | Artem Y Vaynman, MD 9500 Euclid Ave, A41, Cleveland, OH 44195-0001 Ph: (216) 444-2744 |
News Archive
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
ExonHit Therapeutics S.A., a drug and diagnostic discovery company, has announced that Merck & Co., Inc. has been granted a non-exclusive license to rights for research only under Patent US 6,881,571.
The U.S. Department of Veterans Affairs announced on Monday a new effort to improve public health by pushing its research and inventions into commercial markets.
Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.
Today, the Chan Zuckerberg Initiative announced $14 million in funding to support 29 interdisciplinary teams and build a network of researchers that will explore emerging ideas regarding the role of inflammation in disease.
› Verified 9 days ago
Jonathan J Rasouli, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic 9500 Euclid Ave S-40, Cleveland, OH 44195 Phone: 216-444-9580 | |
Eric Herring, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-3472 | |
Prakash Kotagal, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Dr. Gene Henry Barnett, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-5381 | |
Dr. Sara Alsulaimani, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave # Na-23, Cleveland, OH 44195 Phone: 440-226-1283 | |
Alan R Cohen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-3004 Fax: 440-449-1555 | |
Dr. Seth Alan Hoffer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave., Dept Of Neurosurgery, Univ Hospitals Of Cleveland, Cleveland, OH 44106 Phone: 216-844-3004 Fax: 216-844-3014 |